Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
Pharma Firms Pressed to Relax Patents for Developing Countries
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown. The Access to Medicine (ATM) Foundation and its investor signatories have urged pharmaceutical companies to improve access to medicines in low- and middle-income countries (LMICs) by accelerating voluntary licence agreements. Voluntary licences are private contractual agreements through which pharmaceutical firms holding patents…
UK Pushed to Catch up with Europe on ESG Ratings
Timeline, scope of regulation currently uncertain, as new proposal seeks to increase quality, transparency and comparability. Plans for UK regulation of ESG ratings providers need to be accelerated to ensure maximum alignment with European rules that were rubber stamped in Brussels this week. Industry experts suggest UK requirements would need to be finalised and in effect from mid-2026. The…